Align Technology price target raised to $349 from $327 at Leerink

Leerink raised the firm’s price target on Align Technology to $349 from $327 and keeps a Market Perform rating on the shares. Align’s upside surprise showed the differentiation in products vs. other concerns across the dental market, with strong margin pull-through alongside better revenue growth, the firm says. Meanwhile, the increased full-year revenue guidance should show both ongoing aligner demand but also contributions from the Lumina scanner launch/ramp and further roll-out of the Invisalign Palatal Expander, notes Leerink.